Compare MIST & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIST | MLSS |
|---|---|---|
| Founded | 2003 | 1989 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.2M | 23.7M |
| IPO Year | N/A | 1995 |
| Metric | MIST | MLSS |
|---|---|---|
| Price | $2.36 | $0.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $6.33 | $1.00 |
| AVG Volume (30 Days) | ★ 5.3M | 1.6M |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,929,517.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $0.63 | $0.28 |
| 52 Week High | $3.06 | $1.39 |
| Indicator | MIST | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 58.88 |
| Support Level | $2.50 | $0.32 |
| Resistance Level | $2.73 | $0.37 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 48.62 | 95.14 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.